PubMed HealthSearch

Biomedical subjects

W H King

Publications and source records attributed to W H King.

15 recordsLinked to original sources

An in vitro evaluation of ionized calcium levels and clotting in red blood cells diluted with lactated Ringer's solution.

The addition of lactated Ringer's solution which contains calcium (RL) to citrated blood products poses a potential risk whenever the level of ionized calcium reaches a concentration capable of catalyzing the coagulation cascade. RL solution is used extensively as both a replacement and a maintenance fluid in the operating room. However, major surgical procedures often require replacement of blood components as well, during the operation. This study examines the in vitro propensity for coagulation when red blood cells (RBC) are diluted with RL. Seven mixtures with different ratios of RBC to RL were prepared from each of 23 units of RBC. These mixtures were analyzed for ionized calcium, total calcium, and pH, and were checked for any indication of coagulation. Nineteen additional RBC units were split into two parts which were mixed with equal volumes of normal saline (NS) or RL. These mixtures were filtered (40 micron) and the weight gain of the paired filters compared. From these studies, the authors identified a threshold value for ionized calcium (0.23 mM/L) below which the probability of clot formation is less than 0.01. This concentration is not reached if the RBC to RL volume ratio is 2:1 or greater. As much as 100 ml of RL can be added to a unit of RBC without exceeding the threshold value. Although not advocating the routine use of RL as a diluent for RBC, the authors conclude that, within the guidelines described, calcium containing salt solutions may be used to dilute blood products.

Blood Coagulation

Coronary risk factors in flying personnel: a progress report.

Since October 1974, the Flight Surgeon's Office at the USAF Hospital Dover has implemented a program of early detection and treatment of coronary risk factors in aircrew personnel. The program is integrated with USAF periodic physical examinations with interval follow-up of members found to have possible risk factors. A report of initial (baseline) findings was presented at the Aerospace Medical Association meeting in May 1975. During the past year, the base did experience one death due to myocardial infarction in an aircrew member, while two others were grounded due to serial ECG changes, consistent with silent myocardial infarction, confirmed by review at the USAF-SAM ECG Library.

Adult

Antihypertensive drug therapy in USAF flying personnel.

The reviewed data concerns hypertensive USAF aircrew members, as available from the WAVR File (July 1973) and the records of the Aeromedical Consultation Service at USAFSAM (1 July 1972-30 June 1973). Of over 6,500 entries in the WAVR File, hypertension was listed as a diagnosis for 754 individuals. Drug therapy had been instituted in 379 cases (50.3%) of the total. Statistics regarding ranks, age groups, and aeronautical ratings are presented. The group included 520 pilots, of whom 268 were receiving drug therapy. Associated medical conditions, e.g., abnormal EKG findings, carbohydrate intolerance, and hyperuriciemia, are presented. Similar data are reviewed for the 84 patients evaluated on the Aeromedical Consultation Service (USAFSAM).

Adult